Search research articles
Contact Us
Filters
Showing results (301-310 of 910) with videos related to
Page
of 91
Sort By:
Journal of the American College of Cardiology
|
February 7, 2025
Antithrombotic Therapy to Minimize Total Events After ACS or PCI in Atrial Fibrillation: Insights From AUGUSTUS
Manasi Tannu, Renato D Lopes, Daniel M Wojdyla, et al.
European Journal of Cardiovascular Nursing
|
November 13, 2018
Exploring patient-provider decision-making for use of anticoagulation for stroke prevention in atrial fibrillation: Results of the INFORM-AF study
Sean D Pokorney, Diane Bloom, Christopher B Granger, et al.
American Heart Journal
|
March 20, 2012
Development and validation of a prioritization rule for obtaining an immediate 12-lead electrocardiogram in the emergency department to identify ST-elevation myocardial infarction
Seth W Glickman, Frances S Shofer, Michael C Wu, et al.
Archives of Internal Medicine
|
July 11, 2007
Primary percutaneous coronary intervention compared with fibrinolysis for myocardial infarction in diabetes mellitus: results from the Primary Coronary Angioplasty vs Thrombolysis-2 trial
Jorik R Timmer, Jan Paul Ottervanger, Menko-Jan de Boer, et al.
Journal of the American Heart Association
|
March 26, 2024
Repeated Measurement of the Novel Atrial Biomarker BMP10 (Bone Morphogenetic Protein 10) Refines Risk Stratification in Anticoagulated Patients With Atrial Fibrillation: Insights From the ARISTOTLE Trial
Konstantinos I Gkarmiris, Johan Lindbäck, John H Alexander, et al.
American Heart Journal
|
June 5, 2017
Corrigendum to 'Association of Standard Clinical and Laboratory Variables with Red Blood Cell Distribution Width (RDW)'[Am. Heart J. (2016) 22-28]
Patrícia O Guimarães, Jie-Lena Sun, Kristian Kragholm, et al.
Circulation
|
August 21, 2002
Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes
Jassim Al Suwaidi, Donal N Reddan, Kathryn Williams, et al.
European Heart Journal
|
October 12, 2017
Relationship between microvascular obstruction and adverse events following primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an individual patient data pooled analysis from seven randomized trials
Suzanne de Waha, Manesh R Patel, Christopher B Granger, et al.
Journal of the American College of Cardiology
|
May 12, 2012
Association of heart rate and outcomes in a broad spectrum of patients with chronic heart failure: results from the CHARM (Candesartan in Heart Failure: Assessment of Reduction in Mortality and morbidity) program
Davide Castagno, Hicham Skali, Madoka Takeuchi, et al.
American Heart Journal
|
November 27, 2008
Design and rationale of CURRENT-OASIS 7: a randomized, 2 x 2 factorial trial evaluating optimal dosing strategies for clopidogrel and aspirin in patients with ST and non-ST-elevation acute coronary syndromes managed with an early invasive strategy
Shamir R Mehta, Jean-Pierre Bassand, Susan Chrolavicius, et al.
Page
of 91
Search research articles
Search
Showing results (301-310 of 910) with videos related to
Sort By:
Page
of 91
Journal of the American College of Cardiology
|
February 7, 2025
Antithrombotic Therapy to Minimize Total Events After ACS or PCI in Atrial Fibrillation: Insights From AUGUSTUS
Manasi Tannu, Renato D Lopes, Daniel M Wojdyla, et al.
European Journal of Cardiovascular Nursing
|
November 13, 2018
Exploring patient-provider decision-making for use of anticoagulation for stroke prevention in atrial fibrillation: Results of the INFORM-AF study
Sean D Pokorney, Diane Bloom, Christopher B Granger, et al.
American Heart Journal
|
March 20, 2012
Development and validation of a prioritization rule for obtaining an immediate 12-lead electrocardiogram in the emergency department to identify ST-elevation myocardial infarction
Seth W Glickman, Frances S Shofer, Michael C Wu, et al.
Archives of Internal Medicine
|
July 11, 2007
Primary percutaneous coronary intervention compared with fibrinolysis for myocardial infarction in diabetes mellitus: results from the Primary Coronary Angioplasty vs Thrombolysis-2 trial
Jorik R Timmer, Jan Paul Ottervanger, Menko-Jan de Boer, et al.
Journal of the American Heart Association
|
March 26, 2024
Repeated Measurement of the Novel Atrial Biomarker BMP10 (Bone Morphogenetic Protein 10) Refines Risk Stratification in Anticoagulated Patients With Atrial Fibrillation: Insights From the ARISTOTLE Trial
Konstantinos I Gkarmiris, Johan Lindbäck, John H Alexander, et al.
American Heart Journal
|
June 5, 2017
Corrigendum to 'Association of Standard Clinical and Laboratory Variables with Red Blood Cell Distribution Width (RDW)'[Am. Heart J. (2016) 22-28]
Patrícia O Guimarães, Jie-Lena Sun, Kristian Kragholm, et al.
Circulation
|
August 21, 2002
Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes
Jassim Al Suwaidi, Donal N Reddan, Kathryn Williams, et al.
European Heart Journal
|
October 12, 2017
Relationship between microvascular obstruction and adverse events following primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an individual patient data pooled analysis from seven randomized trials
Suzanne de Waha, Manesh R Patel, Christopher B Granger, et al.
Journal of the American College of Cardiology
|
May 12, 2012
Association of heart rate and outcomes in a broad spectrum of patients with chronic heart failure: results from the CHARM (Candesartan in Heart Failure: Assessment of Reduction in Mortality and morbidity) program
Davide Castagno, Hicham Skali, Madoka Takeuchi, et al.
American Heart Journal
|
November 27, 2008
Design and rationale of CURRENT-OASIS 7: a randomized, 2 x 2 factorial trial evaluating optimal dosing strategies for clopidogrel and aspirin in patients with ST and non-ST-elevation acute coronary syndromes managed with an early invasive strategy
Shamir R Mehta, Jean-Pierre Bassand, Susan Chrolavicius, et al.
Page
of 91